Mon, November 13, 2023
Sun, November 12, 2023
Fri, November 10, 2023
Thu, November 9, 2023

Gregory Renza Maintained (APTO) at Buy with Decreased Target to $18 on, Nov 10th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-18-on-nov-10th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Gregory Renza of RBC Capital, Maintained "Aptose Biosciences Inc." (APTO) at Buy with Decreased Target from $23 to $18 on, Nov 10th, 2023.

Gregory has made no other calls on APTO in the last 4 months.



There are 4 other peers that have a rating on APTO. Out of the 4 peers that are also analyzing APTO, 0 agree with Gregory's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Gregory


  • Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $38 on, Thursday, September 7th, 2023
  • Matthew Biegler of "Oppenheimer" Maintained at Buy with Decreased Target to $15 on, Friday, August 11th, 2023
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Decreased Target to $12 on, Friday, August 11th, 2023
  • Joseph Pantginis of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $23 on, Friday, August 11th, 2023

Publication Contributing Sources